MetLife Investment Management, LLC
Position in ANIK — Anika Therapeutics, Inc.
CIK 1529735
Whippany, NJ
Position in ANIK
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$103,269
-$24,726 QoQ
Shares Held
7,122
-16.4% QoQ
Ownership
0.054%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANIK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026MetLife Investment Management, LLC holds $88,544,808 across 37 Drug Manufacturers - Specialty & Generic names. ANIK ranks #32 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SUPN |
Supernus Pharmaceuticals, Inc.
|
304,172 | $15,722,650 | |
| 2 | ZTS |
Zoetis Inc.
|
114,814 | $13,572,162 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
21,171 | $12,553,979 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
53,053 | $6,989,202 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
244,343 | $5,847,127 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
67,088 | $5,088,624 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
211,317 | $4,386,940 | |
| 8 | VTRS |
Viatris Inc
|
269,168 | $3,636,459 |
All Filings in ANIK
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $103,269 | 7,122 | Shares | Defined | 2026-05-14 | |
| 2025-03-31 | $127,995 | 8,516 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $140,173 | 8,516 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $210,345 | 8,516 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $215,710 | 8,516 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $195,199 | 7,685 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $174,142 | 7,685 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $143,171 | 7,685 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $199,656 | 7,685 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $220,713 | 7,685 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $227,476 | 7,685 | Shares | Defined | 2023-03-23 | |
| 2022-09-30 | $203,014 | 8,530 | Shares | Defined | 2023-03-23 | |
| 2022-06-30 | $190,389 | 8,530 | Shares | Defined | 2023-03-23 | |
| 2022-03-31 | $214,188 | 8,530 | Shares | Defined | 2023-03-23 | |
| 2021-12-31 | $177,286 | 4,948 | Shares | Defined | 2023-03-23 | |
| 2021-09-30 | $301,622 | 7,087 | Shares | Defined | 2023-03-23 | |
| 2021-06-30 | $306,796 | 7,087 | Shares | Defined | 2023-03-23 | |
| 2021-03-31 | $289,078 | 7,087 | Shares | Defined | 2023-03-23 | |
| 2020-12-31 | $320,757 | 7,087 | Shares | Defined | 2023-03-23 | |
| 2020-09-30 | $250,808 | 7,087 | Shares | Defined | 2023-03-23 | |
| 2020-06-30 | $267,392 | 7,087 | Shares | Defined | 2023-03-23 | |
| 2020-03-31 | $204,885 | 7,087 | Shares | Defined | 2023-03-23 | |
| No filing history on record for this holder in this stock. | ||||||